Cargando…
Mapping loss of heterozygosity in normal human breast cells from BRCA1/2 carriers
We have studied loss of heterozygosity at the BRCA1 and BRCA2 loci in 992 normal cell clones derived from topographically defined areas of normal tissue in four samples from BRCA1/BRCA2 mutation carriers. The frequency of loss of heterozygosity in the clones was low (1.01%), but it was found in all...
Autores principales: | Clarke, C L, Sandle, J, Jones, A A, Sofronis, A, Patani, N R, Lakhani, S R |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360661/ https://www.ncbi.nlm.nih.gov/pubmed/16880780 http://dx.doi.org/10.1038/sj.bjc.6603298 |
Ejemplares similares
-
DNA repair capacity as a possible biomarker of breast cancer risk in female BRCA1 mutation carriers
por: Kotsopoulos, J, et al.
Publicado: (2007) -
Genetic instability in lung cancer: concurrent analysis of chromosomal, mini- and microsatellite instability and loss of heterozygosity
por: Ninomiya, H, et al.
Publicado: (2006) -
BRCA locus-specific loss of heterozygosity in germline BRCA1 and BRCA2 carriers
por: Maxwell, Kara N., et al.
Publicado: (2017) -
Association between cytosolic expression of BRCA1 and metastatic risk in breast cancer
por: Santivasi, W L, et al.
Publicado: (2015) -
Evaluation of models to predict BRCA germline mutations
por: Kang, H H, et al.
Publicado: (2006)